109 related articles for article (PubMed ID: 6979010)
1. [Initial immunologic evaluations in breast and thyroid cancer].
Abeatici S; Mussa A; Levis P; Sandrucci S; Storta P
Minerva Med; 1982 Apr; 73(18):1149-54. PubMed ID: 6979010
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of percentage of T-lymphocytes in blood in patients with breast and thyroid cancer.
Smejkalová E; Sloboda J; Smejkal V; Zamrazil V
Czech Med; 1986; 9(1):51-6. PubMed ID: 3086060
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
[TBL] [Abstract][Full Text] [Related]
4. Elevated CEA in breast cancer patients with overlooked medullary thyroid carcinoma.
Andry G; Wildschutz T; Chantrain G; Bonnyns M; Dor P
Eur J Surg Oncol; 1993 Jun; 19(3):305-8. PubMed ID: 8100201
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
6. [Disorders of the immune system in benign lesions and cancer of the breast].
Derevnina NA; Polevaia EB; Veskova TK; Trubcheninova LP; Bogatyrev VN
Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960
[TBL] [Abstract][Full Text] [Related]
7. [Circulating immune complexes and immunologic reactivity in breast cancer].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
[TBL] [Abstract][Full Text] [Related]
8. Rhythmic fluctuations of CEA serum levels in breast cancer patients.
Jäger W; Diedrich M; Sauerbrei W; Wildt L
Anticancer Res; 1987; 7(4B):711-5. PubMed ID: 3674759
[TBL] [Abstract][Full Text] [Related]
9. Variations of serum carcinoembryonic antigen, alpha-fetoprotein and immunoglobulin levels in patients with breast cancer.
Vântu A; Bălănescu I; Stafidov N; Voiculeţ N
Med Interne; 1982; 20(2):151-5. PubMed ID: 6181552
[TBL] [Abstract][Full Text] [Related]
10. [Dynamic sampling analysis of the immune status of breast cancer patients].
Eremina OF; Kunitsyna TA; Sharonina AI
Vopr Onkol; 1985; 31(6):33-7. PubMed ID: 3875181
[TBL] [Abstract][Full Text] [Related]
11. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
Machens A; Ukkat J; Hauptmann S; Dralle H
Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055
[TBL] [Abstract][Full Text] [Related]
12. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3.
Lumachi F; Brandes AA; Boccagni P; Polistina F; Favia G; D'Amico DF
Anticancer Res; 1999; 19(5C):4485-9. PubMed ID: 10650797
[TBL] [Abstract][Full Text] [Related]
14. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
[TBL] [Abstract][Full Text] [Related]
15. [Immunologic reactivity of breast cancer patients].
Semiglazov VF; Kondrat'ev VB; Mar'enko AI; L'vovich EG; Sofronov BN
Vopr Onkol; 1978; 24(8):74-9. PubMed ID: 695430
[TBL] [Abstract][Full Text] [Related]
16. [Cellular immunologic parameters in thyroid diseases].
Beyer PA; Wenisch HJ; Schumm-Draeger PM; Hanisch E; Seufert RM; Encke A
Acta Med Austriaca; 1989; 16(1):6-7. PubMed ID: 2785324
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal and immunological changes in breast cancers with different growth rates].
Balmukhanov SB; Zhalgasbaeva GT; Kurralasov AK; Baisheva SA; Togaĭbaeva ZI
Vopr Onkol; 1989; 35(11):1319-22. PubMed ID: 2609521
[TBL] [Abstract][Full Text] [Related]
18. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer.
Jotsuka T; Okumura Y; Nakano S; Nitta H; Sato T; Miyachi M; Suzumura K; Yamashita J
Surgery; 2004 Apr; 135(4):419-26. PubMed ID: 15041966
[TBL] [Abstract][Full Text] [Related]
19. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
Ramey WG; Hashim GA; Burrows WB; Swistel AJ; Munther A; Fitzpatrick HF
Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
[No Abstract] [Full Text] [Related]
20. Serum tissue polypeptide specific antigen (TPS) in breast cancer patients: comparison with CA 15.3 and CEA.
Willsher PC; Beaver J; Blamey RW; Robertson JF
Anticancer Res; 1995; 15(4):1609-11. PubMed ID: 7654057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]